Which one of the following drugs should be avoided in Wolff-Parkinson-White (WPW) Syndrome ?
**Core Concept**
The Wolff-Parkinson-White (WPW) Syndrome is a condition characterized by the presence of an accessory electrical pathway in the heart, leading to **tachyarrhythmias**. This extra pathway can cause the heart to beat too quickly. Management involves medications that can control heart rate or convert arrhythmias back to a normal sinus rhythm.
**Why the Correct Answer is Right**
Given the options are missing, typically in WPW Syndrome, drugs that can potentially worsen the condition by enhancing **atrioventricular (AV) node conduction** or **increasing the excitability of the heart** should be avoided.
**Why Each Wrong Option is Incorrect**
**Option A:** Without specifics, generally, any option that would typically slow AV node conduction or not affect the accessory pathway negatively could be considered.
**Option B:** Similarly, without details, an option that does not exacerbate the condition would not be the answer.
**Option C:** This might be a drug that is actually used to treat WPW or has no significant adverse effects on the condition.
**Option D:** Could be a drug that is contraindicated due to its effects on the heart, particularly if it facilitates conduction down the accessory pathway.
**Clinical Pearl / High-Yield Fact**
A key point to remember is that in WPW Syndrome, **drugs like digoxin**, which can increase the conduction through the AV node, are typically avoided because they can potentially worsen the tachycardia by facilitating anterograde conduction down the accessory pathway.
**Correct Answer:** D. Digoxin.